New hope for rare tumor patients: chemo delivered directly to desmoid growths

NCT ID NCT06268457

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for people with symptomatic desmoid tumors that are growing and cannot be treated with surgery or freezing. Researchers are testing a procedure that delivers chemotherapy (doxorubicin) directly into the tumor through a small tube in an artery, aiming to shrink the tumor and reduce pain. The study will follow 20 participants over time to see if this approach is safe and effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DESMOID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istituto Ortopedico Rizzoli

    RECRUITING

    Bologna, Emilia-Romagna, 40136, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.